The application of the combined corticotropin-releasing hormone plus desmopressin stimulation during petrosal sinus sampling is both sensitive and specific in differentiating patients with Cushing's disease from patients with the occult ectopic adrenocorticotropin syndrome

J Clin Endocrinol Metab. 2007 Jun;92(6):2080-6. doi: 10.1210/jc.2006-2691. Epub 2007 Mar 13.

Abstract

Context: Although bilateral inferior petrosal sinus sampling (BIPSS) with CRH stimulation is the most accurate procedure for the differential diagnosis of ACTH-dependent Cushing's syndrome (CS), 4-15% of patients with Cushing's disease (CD) fail to demonstrate diagnostic gradients. Preliminary data suggest that a more potent stimulation by the combined administration of CRH plus desmopressin during BIPSS may provide some diagnostic advantage. A crucial issue, however, is whether such an amplified stimulation may affect the specificity of the procedure, and this was the main aim of the present study.

Objective: We investigated the diagnostic accuracy of BIPSS performed by CRH plus desmopressin stimulation.

Design and setting: A retrospective analysis was conducted at a single tertiary care center.

Participants: Fifty-four patients were admitted for the investigation of ACTH-dependent CS. CD was diagnosed in 47 patients; occult ectopic ACTH syndrome (oEAS) was histologically confirmed in seven patients.

Intervention(s): All patients underwent BIPSS with CRH plus desmopressin administration. Additional noninvasive tests included CRH test, high-dose dexamethasone suppression test, desmopressin test, and pituitary magnetic resonance imaging.

Main outcome measures: Gradients of inferior petrosal sinus (IPS) to peripheral (IPS/P) ACTH were calculated before and after stimulation with CRH plus desmopressin.

Results: The sensitivity for a basal IPS/P gradient greater than 2 was 61.7%, with 100% specificity and a diagnostic accuracy of 66.7%. After stimulation with CRH plus desmopressin, receiver operating characteristic (ROC) curve analysis showed that a cutoff gradient of more than 2 offers the best test performance. In total, 46 of 47 patients with CD had an IPS/P gradient greater than 2, but none of the patients with oEAS, resulting in a sensitivity of 97.9%. The specificity was 100%, diagnostic accuracy was 98.2%, and the positive and negative predictive values were 100 and 87.5%, respectively. A subgroup of 18 patients (16 with CD and two with oEAS) had contradictory responses to routine tests with CRH and/or high-dose dexamethasone suppression test; sensitivity, specificity, and accuracy of BIPSS in this subgroup were 100%.

Conclusions: The application of a combined stimulation with CRH plus desmopressin during BIPSS is associated with a high sensitivity but no loss of specificity.

MeSH terms

  • ACTH Syndrome, Ectopic / diagnosis*
  • Adult
  • Antidiuretic Agents* / administration & dosage
  • Corticotropin-Releasing Hormone* / administration & dosage
  • Deamino Arginine Vasopressin* / administration & dosage
  • Diagnosis, Differential
  • Female
  • Humans
  • Male
  • Middle Aged
  • Petrosal Sinus Sampling
  • Pituitary ACTH Hypersecretion / diagnosis*
  • Retrospective Studies
  • Sensitivity and Specificity

Substances

  • Antidiuretic Agents
  • Corticotropin-Releasing Hormone
  • Deamino Arginine Vasopressin